| P50 | author | Paola Cassoni | Q91113847 |
| | Giampiero Muccioli | Q57339687 |
| P2093 | author name string | Fabio Lanfranco | |
| | Corrado Ghé | |
| | Martino Bosco | |
| | Matteo Baldi | |
| P2860 | cites work | Identification, Characterization, and Biological Activity of Specific Receptors for Natural (Ghrelin) and Synthetic Growth Hormone Secretagogues and Analogs in Human Breast Carcinomas and Cell Lines | Q60286326 |
| | Endocrine Activities of Ghrelin, a Natural Growth Hormone Secretagogue (GHS), in Humans: Comparison and Interactions with Hexarelin, a Nonnatural Peptidyl GHS, and GH-Releasing Hormone | Q60674309 |
| | Expression of the Growth Hormone Secretagogue Receptor in Pituitary Adenomas and Other Neuroendocrine Tumors | Q61942609 |
| | Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. | Q64955588 |
| | Intracerebroventricular growth-hormone-releasing peptide-6 stimulates eating without affecting plasma growth hormone responses in rats | Q71040673 |
| | Prospective study of plasma fatty acids and risk of prostate cancer | Q72365231 |
| | Prostate cancer cell-adipocyte interaction: leptin mediates androgen-independent prostate cancer cell proliferation through c-Jun NH2-terminal kinase | Q73764667 |
| | Ghrelin/motilin-related peptide is a potent prokinetic to reverse gastric postoperative ileus in rat | Q74117993 |
| | Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation | Q74345525 |
| | Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention | Q74405050 |
| | Hepatitis B vaccine and liver problems in U.S. children less than 6 years old, 1993 and 1994 | Q77407917 |
| | Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer | Q78225972 |
| | Effects of ghrelin and des-acyl ghrelin on neurogenesis of the rat fetal spinal cord | Q79206561 |
| | Acylated and unacylated ghrelin promote proliferation and inhibit apoptosis of pancreatic beta-cells and human islets: involvement of 3',5'-cyclic adenosine monophosphate/protein kinase A, extracellular signal-regulated kinase 1/2, and phosphatidyl | Q79306155 |
| | Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors | Q22003987 |
| | Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 |
| | A receptor in pituitary and hypothalamus that functions in growth hormone release | Q24308321 |
| | Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation | Q24317092 |
| | Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors | Q24322735 |
| | Cancer statistics, 2002 | Q28216788 |
| | Ghrelin cells replace insulin-producing beta cells in two mouse models of pancreas development | Q28245759 |
| | Inhibition of pancreatic protein secretion by ghrelin in the rat | Q28364374 |
| | Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes | Q28575190 |
| | A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes | Q28590335 |
| | Leptin and the regulation of body weight in mammals | Q29615976 |
| | A central role for JNK in obesity and insulin resistance | Q29619778 |
| | Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines | Q30821767 |
| | Insulin-like growth factors and prostate cancer | Q33715198 |
| | Insulin-like growth factor-I and binding protein-3 and risk of cancer | Q33791378 |
| | Growth hormone (GH)-independent stimulation of adiposity by GH secretagogues | Q33931979 |
| | Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study | Q34065827 |
| | Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues | Q34089016 |
| | Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. | Q34229787 |
| | Family history and the risk of prostate cancer | Q34268953 |
| | Estrogen receptor beta in prostate cancer: brake pedal or accelerator? | Q34299700 |
| | Adiponectin and breast cancer risk | Q34303243 |
| | Circulating adiponectin and endometrial cancer risk | Q34303251 |
| | Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes | Q34366657 |
| | Novel B219/OB receptor isoforms: possible role of leptin in hematopoiesis and reproduction | Q34377303 |
| | Ghrelin: structure and function | Q34406050 |
| | Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study | Q34473008 |
| | Ghrelin stimulates gastric acid secretion and motility in rats | Q34511311 |
| | Substantial production of ghrelin by a human medullary thyroid carcinoma cell line | Q34518377 |
| | Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity | Q34635506 |
| | Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part I: international comparisons | Q34703693 |
| | The underlying basis for obesity: relationship to cancer | Q34992018 |
| | The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. | Q35090138 |
| | Role of MAP kinase in tumor progression and invasion | Q35186460 |
| | Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates | Q35645365 |
| | Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin | Q35794412 |
| | Ghrelin and synthetic growth hormone secretagogues are cardioactive molecules with identities and differences. | Q35915129 |
| | Ghrelin and reproduction: a novel signal linking energy status and fertility? | Q35920399 |
| | Ghrelin: more than a natural GH secretagogue and/or an orexigenic factor | Q36003115 |
| | Hormonal, cellular, and molecular regulation of normal and neoplastic prostatic development | Q36017017 |
| | Sex steroid hormone metabolism and prostate cancer | Q36017042 |
| | The CAG repeat within the androgen receptor gene and its relationship to prostate cancer | Q36085009 |
| | Ghrelin, the same peptide for different functions: player or bystander? | Q36236097 |
| | Growth hormone secretagogue (ghrelin-) receptors--a complex drug target for the regulation of body weight | Q36512887 |
| | Ghrelin and the short- and long-term regulation of appetite and body weight | Q36543303 |
| | Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. | Q36892107 |
| | Biological action of leptin as an angiogenic factor | Q38333557 |
| | Prostate cancer cell proliferation is influenced by leptin | Q38342304 |
| | Risk factors for prostate cancer: a case-control study in Greece | Q39488073 |
| | Ghrelin and cortistatin in lung cancer: expression of peptides and related receptors in human primary tumors and in vitro effect on the H345 small cell carcinoma cell line | Q40206428 |
| | The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer | Q40224129 |
| | Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines | Q40344901 |
| | Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer | Q40344921 |
| | Prostate cancer and adiponectin. | Q40418631 |
| | Expression of ghrelin and biological activity of specific receptors for ghrelin and des-acyl ghrelin in human prostate neoplasms and related cell lines | Q40592416 |
| | Steroid 5 alpha-reductase: two genes/two enzymes | Q40643006 |
| | Structural divergence of human ghrelin. Identification of multiple ghrelin-derived molecules produced by post-translational processing | Q40692602 |
| | Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin | Q40729865 |
| | The antiproliferative effect of synthetic peptidyl GH secretagogues in human CALU-1 lung carcinoma cells | Q40756715 |
| | Structure-function studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. | Q40840986 |
| | Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer | Q40970843 |
| | Age and racial distribution of prostatic intraepithelial neoplasia. | Q41170151 |
| | Mitogen-activated protein kinase pathway is involved in alpha6 integrin gene expression in androgen-independent prostate cancer cells: role of proximal Sp1 consensus sequence. | Q42503858 |
| | Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor | Q42506962 |
| | Ghrelin effects on gonadotropin secretion in male and female rats | Q42629198 |
| | Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein | Q42811136 |
| | Intracerebroventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats | Q43786272 |
| | Ghrelin promotes slow-wave sleep in humans | Q44185406 |
| | Stimulatory effects of ghrelin on circulating somatostatin and pancreatic polypeptide levels | Q44306827 |
| | The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects | Q44392855 |
| | Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. | Q44398229 |
| | Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans | Q44457632 |
| | Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy | Q44818662 |
| | Identification and functional characterization of two alternatively spliced growth hormone secretagogue receptor transcripts from the pituitary of black seabream Acanthopagrus schlegeli | Q44828443 |
| | Differential effects of leptin on cancer in vitro | Q44895551 |
| | Ghrelin stimulates neurogenesis in the dorsal motor nucleus of the vagus | Q44991714 |
| | Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghrelin infusion in the ovariectomized rhesus monkey | Q45142869 |
| | Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer. | Q46023216 |
| | Effects of chronic hyperghrelinemia on puberty onset and pregnancy outcome in the rat. | Q46404257 |
| | Racial treatment trends in localized/regional prostate carcinoma: 1992-1999. | Q46458824 |
| | Endogenous sex hormone levels in older adult men with diabetes mellitus | Q46489714 |
| | Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and cortisol secretion in sheep. | Q46739952 |
| | Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release | Q48330103 |
| | Effects of Ghrelin on growth hormone secretion from cultured adenohypophysial cells in pigs | Q48362415 |
| | Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion | Q48388161 |
| | Ghrelin Inhibits the Development of Mouse Preimplantation Embryos in Vitro | Q48828891 |
| | Intracerebroventricular administration of the growth hormone-releasing peptide KP-102 increases food intake in free-feeding rats | Q48883021 |
| | Differential orexigenic effects of hexarelin and its analogs in the rat hypothalamus: indication for multiple growth hormone secretagogue receptor subtypes | Q49105514 |
| | Leptin in relation to prostate cancer and benign prostatic hyperplasia. | Q50897720 |
| | Up-regulation of IGF binding protein-1 as an anticarcinogenic strategy: relevance to caloric restriction, exercise, and insulin sensitivity. | Q50954640 |
| | Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. | Q51035704 |
| | Role for central ghrelin in food intake and secretion profile of stomach ghrelin in rats. | Q51541297 |
| | Insulin-like growth factor-I and insulin-like growth factor binding protein-1 in a representative population of type 2 diabetic patients in Sweden. | Q51567996 |
| | Diabetes mellitus and risk of prostate cancer (United States). | Q52900922 |
| | Androgen receptor mutations in high-grade prostate cancer before hormonal therapy. | Q54736431 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 301-324 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Vitamins and Hormones | Q15753296 |
| P1476 | title | Ghrelin and prostate cancer | |
| P478 | volume | 77 | |